Cargando…
The Role of PARP Inhibitors in the Treatment of Gynecologic Malignancies
Gynecologic malignancies annually account for over 91,000 new cancer cases and approximately 28,000 deaths in the United States. Although there have been advancements in cytotoxic chemotherapies, there has not been significant improvement in overall survival in these patients. While targeted therapi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787651/ https://www.ncbi.nlm.nih.gov/pubmed/24098868 http://dx.doi.org/10.3389/fonc.2013.00237 |